| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 28/11/2023 | 00:05 | Business Wire | CohBar, Inc.: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (Form 8-K) | NASDAQ:CWBR | CohBar Inc |
| 27/11/2023 | 23:21 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:CWBR | CohBar Inc |
| 25/10/2023 | 15:01 | Edgar (US Regulatory) | Form 425 - Prospectuses and communications, business combinations | NASDAQ:CWBR | CohBar Inc |
| 06/10/2023 | 22:11 | Edgar (US Regulatory) | Form 8-K/A - Current report: [Amend] | NASDAQ:CWBR | CohBar Inc |
| 13/09/2023 | 06:15 | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness | NASDAQ:CWBR | CohBar Inc |
| 12/09/2023 | 22:47 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] | NASDAQ:CWBR | CohBar Inc |
| 12/09/2023 | 19:44 | Edgar (US Regulatory) | Form S-4/A - Registration of securities, business combinations: [Amend] | NASDAQ:CWBR | CohBar Inc |
| 14/08/2023 | 22:07 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:CWBR | CohBar Inc |
| 14/08/2023 | 22:01 | GlobeNewswire Inc. | CohBar Reports Second Quarter 2023 Financial Results | NASDAQ:CWBR | CohBar Inc |
| 05/06/2023 | 14:05 | GlobeNewswire Inc. | Morphogenesis, Inc. and CohBar, Inc. Announce Positive Results from Phase 1b Trial of IFx-Hu2.0, a Novel Personalized Cancer Vaccine, in Checkpoint Inhibitor Resistant Advanced Merkel Cell Carcinoma (MCC) and Cutaneous Squamous Cell Carcinoma (cSCC) | NASDAQ:CWBR | CohBar Inc |
| 31/05/2023 | 22:51 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:CWBR | CohBar Inc |
| 30/05/2023 | 14:05 | GlobeNewswire Inc. | Morphogenesis, Inc. and CohBar, Inc. Announce Acceptance of Abstract for Poster Presentation at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting | NASDAQ:CWBR | CohBar Inc |
| 23/05/2023 | 13:30 | GlobeNewswire Inc. | CohBar, Inc. and Morphogenesis, Inc. Enter into Definitive Merger Agreement to Advance an Innovative Late-stage Clinical Immuno-oncology Pipeline of Therapies to Overcome Resistance to Cancer Immunotherapy | NASDAQ:CWBR | CohBar Inc |
| 15/05/2023 | 14:33 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:CWBR | CohBar Inc |
| 28/04/2023 | 15:01 | Edgar (US Regulatory) | Amended Annual Report (10-k/a) | NASDAQ:CWBR | CohBar Inc |
| 09/03/2023 | 22:12 | Edgar (US Regulatory) | Annual Report (10-k) | NASDAQ:CWBR | CohBar Inc |
| 08/02/2023 | 15:01 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:CWBR | CohBar Inc |
| 07/12/2022 | 15:00 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:CWBR | CohBar Inc |
| 08/11/2022 | 22:03 | GlobeNewswire Inc. | CohBar Reports Third Quarter 2022 Financial Results and Highlights Recent Corporate Progress | NASDAQ:CWBR | CohBar Inc |
| 26/10/2022 | 15:00 | GlobeNewswire Inc. | CohBar to Announce 2022 Third Quarter Financial Results and Provide Business Update on November 8, 2022 | NASDAQ:CWBR | CohBar Inc |
| 22/09/2022 | 15:00 | GlobeNewswire Inc. | CohBar Announces Reverse Stock Split | NASDAQ:CWBR | CohBar Inc |
| 06/09/2022 | 15:00 | GlobeNewswire Inc. | CohBar to Present at H.C. Wainwright 24th Annual Global Investment Conference | NASDAQ:CWBR | CohBar Inc |
| 15/08/2022 | 22:02 | GlobeNewswire Inc. | CohBar Reports Second Quarter 2022 Financial Results and Highlights Recent Corporate Progress | NASDAQ:CWBR | CohBar Inc |
| 03/08/2022 | 15:01 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CWBR | CohBar Inc |
| 01/08/2022 | 15:00 | GlobeNewswire Inc. | CohBar to Announce 2022 Second Quarter Financial Results and Provide Business Update on August 15, 2022 | NASDAQ:CWBR | CohBar Inc |
| 12/07/2022 | 22:06 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:CWBR | CohBar Inc |
| 12/07/2022 | 15:00 | GlobeNewswire Inc. | CohBar Appoints Effie Tozzo, Ph.D. to Its Board of Directors | NASDAQ:CWBR | CohBar Inc |
| 07/06/2022 | 15:00 | GlobeNewswire Inc. | CohBar to Participate at Upcoming Conferences in June 2022 | NASDAQ:CWBR | CohBar Inc |
| 24/05/2022 | 22:06 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | NASDAQ:CWBR | CohBar Inc |
| 19/05/2022 | 22:02 | GlobeNewswire Inc. | CohBar to Present at the H.C. Wainwright Global Investment Conference | NASDAQ:CWBR | CohBar Inc |